Bone Solutions surpassed 500 successfully implanted cases using OsteoCrete® bone void filler. This is an increase from the 250 implant milestone, as reported in 4Q18.
OsteoCrete is the first bone void filler in the U.S. to incorporate magnesium oxide to enhance bone development. It is 100% resorbable and also injectable, moldable and biocompatible, and cleared for use in a range of treatments such as complex sport-related injuries to all musculoskeletal extremities trauma cases.
Bone Solutions is ramping up full commercialization of OsteoCrete with regional and national orthopedic manufacturers and distributors.
Sources: Bone Solutions Inc.; ORTHOWORLD Inc.